|
|
|
Volumn 34, Issue 3, 1999, Pages 211-219
|
|
A TNF-receptor blocker for treating patients with refractory rheumatoid arthritis
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANTIRHEUMATIC AGENT;
BIOLOGICAL RESPONSE MODIFIER;
ETANERCEPT;
METHOTREXATE;
PLACEBO;
RECEPTOR BLOCKING AGENT;
TUMOR NECROSIS FACTOR RECEPTOR;
UNCLASSIFIED DRUG;
ADULT;
AGED;
CLINICAL TRIAL;
COMPETITIVE INHIBITION;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DOUBLE BLIND PROCEDURE;
DRUG APPROVAL;
DRUG EFFICACY;
DRUG HALF LIFE;
DRUG SAFETY;
DRUG TOLERANCE;
FEMALE;
HUMAN;
MAJOR CLINICAL STUDY;
MALE;
MEMBRANE BINDING;
PHASE 2 CLINICAL TRIAL;
PHASE 3 CLINICAL TRIAL;
RANDOMIZED CONTROLLED TRIAL;
RECEPTOR BINDING;
REVIEW;
RHEUMATOID ARTHRITIS;
|
|
EID: 0033037013
PISSN: 1082801X
EISSN: None
Source Type: Journal
DOI: None Document Type: Review |
|
Times cited : (2)
|
|
References (20)
|
